Log in to save to my catalogue

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the man...

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the man...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1943075ceb3442f28ca3f0d6fae4550c

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

About this item

Full title

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Publisher

England: BioMed Central Ltd

Journal title

Journal for immunotherapy of cancer, 2018-10, Vol.6 (1), p.103-103, Article 103

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Immune-related enterocolitis (irEC) is the most common serious complication from checkpoint inhibitors (CPIs). The current front-line treatment for irEC, high-dose corticosteroids (CS), have significant side effects and prolonged therapy may reduce CPI-anti-tumor activity. Early addition of TNF-α inhibitors such as infliximab (IFX) may expedite sym...

Alternative Titles

Full title

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1943075ceb3442f28ca3f0d6fae4550c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1943075ceb3442f28ca3f0d6fae4550c

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/s40425-018-0412-0

How to access this item